FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2466366908> ?p ?o ?g. }

• W2466366908 endingPage "4" @default.
• W2466366908 startingPage "781" @default.
• W2466366908 abstract "To validate the immunogenicity of Mycobacterium smegmatis and to study the immune modulatory function of Mycobacterium smegmatis vaccine made from Mycobacterium smegmatis by analyzing the effects of the vaccine on immune responses in mice.Spleen cells and peritoneal macrophages from BALB/c mice which were randomized into a control group and Mycobacterium smegmatis vaccine groups (low, middle, and high doses) were cultured in vitro. Then the supernatants were collected and the concentrations of IL-2, IL-4, IL-12, and IFN-gamma were analyzed through ELISA.(1) IL-12 produced by the control mice and mice immunized with low, middle, high doses of Mycobacterium smegmatis vaccine was (32.6 +/- 22.7), (58.9 +/- 18.6), (77.3 +/- 38.0), (114.7 +/- 9.9) pg/ml respectively, and the middle and high dose group showed significant difference as compared with the control group (P < 0.05). (2) IL-2 produced by the control mice and mice immunized with low, middle, high dose of Mycobacterium smegmatis vaccine was (5.0 +/- 2.6), (13.4 +/- 9.23), (15.3 +/- 9.7), (22.6 +/- 7.5) pg/ml respectively, and the high dose group showed significant difference when compared with the control group (P < 0.01). (3) When the cells were stimulated with ConA in vitro, IFN-gamma produced by the control mice and mice immunized with middle dose of Mycobacterium smegmatis vaccine was (662 +/- 279) and (807 +/- 163) pg/ml, IL-4 produced by the two groups was (407 +/- 127) and (101 +/- 26) pg/ml, but the differences were not statistically significant (P > 0.05). When the cells were stimulated with Mycobacterium smegmatis-purified protein derivative (PPD) in vitro, IFN-gamma produced by the control mice and mice immunized with middle dose of Mycobacterium smegmatis vaccine was (14.0 +/- 6.31) and (55.3 +/- 32.4) pg/ml, the difference being statistically significant (P < 0.05), but IL-4 produced by the two groups was under the limit of detection.Mycobacterium smegmatis vaccine made from Mycobacterium smegmatis showed strong immunogenicity promoted Th1 responses and inhibited Th2 response in mice." @default.
• W2466366908 created "2016-07-22" @default.
• W2466366908 creator A5001045957 @default.
• W2466366908 creator A5013892734 @default.
• W2466366908 creator A5036785387 @default.
• W2466366908 creator A5053292671 @default.
• W2466366908 creator A5076731949 @default.
• W2466366908 creator A5081825149 @default.
• W2466366908 date "2005-11-01" @default.
• W2466366908 modified "2023-09-29" @default.
• W2466366908 title "[Effects of Mycobacterium smegmatis vaccine on cytokines production and Th1/Th2 responses in mice]." @default.
• W2466366908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16324276" @default.
• W2466366908 hasPublicationYear "2005" @default.
• W2466366908 type Work @default.
• W2466366908 sameAs 2466366908 @default.
• W2466366908 citedByCount "1" @default.
• W2466366908 countsByYear W24663669082023 @default.
• W2466366908 crossrefType "journal-article" @default.
• W2466366908 hasAuthorship W2466366908A5001045957 @default.
• W2466366908 hasAuthorship W2466366908A5013892734 @default.
• W2466366908 hasAuthorship W2466366908A5036785387 @default.
• W2466366908 hasAuthorship W2466366908A5053292671 @default.
• W2466366908 hasAuthorship W2466366908A5076731949 @default.
• W2466366908 hasAuthorship W2466366908A5081825149 @default.
• W2466366908 hasConcept C142724271 @default.
• W2466366908 hasConcept C203014093 @default.
• W2466366908 hasConcept C2777204207 @default.
• W2466366908 hasConcept C2777975735 @default.
• W2466366908 hasConcept C2780374374 @default.
• W2466366908 hasConcept C2780868878 @default.
• W2466366908 hasConcept C2781069245 @default.
• W2466366908 hasConcept C523546767 @default.
• W2466366908 hasConcept C54355233 @default.
• W2466366908 hasConcept C71924100 @default.
• W2466366908 hasConcept C86803240 @default.
• W2466366908 hasConcept C8891405 @default.
• W2466366908 hasConcept C89423630 @default.
• W2466366908 hasConceptScore W2466366908C142724271 @default.
• W2466366908 hasConceptScore W2466366908C203014093 @default.
• W2466366908 hasConceptScore W2466366908C2777204207 @default.
• W2466366908 hasConceptScore W2466366908C2777975735 @default.
• W2466366908 hasConceptScore W2466366908C2780374374 @default.
• W2466366908 hasConceptScore W2466366908C2780868878 @default.
• W2466366908 hasConceptScore W2466366908C2781069245 @default.
• W2466366908 hasConceptScore W2466366908C523546767 @default.
• W2466366908 hasConceptScore W2466366908C54355233 @default.
• W2466366908 hasConceptScore W2466366908C71924100 @default.
• W2466366908 hasConceptScore W2466366908C86803240 @default.
• W2466366908 hasConceptScore W2466366908C8891405 @default.
• W2466366908 hasConceptScore W2466366908C89423630 @default.
• W2466366908 hasIssue "11" @default.
• W2466366908 hasLocation W24663669081 @default.
• W2466366908 hasOpenAccess W2466366908 @default.
• W2466366908 hasPrimaryLocation W24663669081 @default.
• W2466366908 hasRelatedWork W1869526161 @default.
• W2466366908 hasRelatedWork W1978406852 @default.
• W2466366908 hasRelatedWork W2010057931 @default.
• W2466366908 hasRelatedWork W2105759992 @default.
• W2466366908 hasRelatedWork W2107800058 @default.
• W2466366908 hasRelatedWork W2120266933 @default.
• W2466366908 hasRelatedWork W2132692212 @default.
• W2466366908 hasRelatedWork W2135617279 @default.
• W2466366908 hasRelatedWork W2906945948 @default.
• W2466366908 hasRelatedWork W3160805482 @default.
• W2466366908 hasVolume "28" @default.
• W2466366908 isParatext "false" @default.
• W2466366908 isRetracted "false" @default.
• W2466366908 magId "2466366908" @default.
• W2466366908 workType "article" @default.